Shanghai Haixin Group Co Ltd A (600851) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haixin Group Co Ltd A (600851) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥72.27 Million ≈ $10.58 Million USD) by net assets (CN¥4.84 Billion ≈ $708.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Shanghai Haixin Group Co Ltd A worth for the company's overall valuation and market capitalisation.
Shanghai Haixin Group Co Ltd A - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Shanghai Haixin Group Co Ltd A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Haixin Group Co Ltd A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haixin Group Co Ltd A ranked by their cash flow conversion efficiency. Explore cash flow quality index of Shanghai Haixin Group Co Ltd A to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
0.006x |
|
Usinas Siderúrgicas de Minas Gerais S.A
SA:USIM3
|
0.015x |
|
Shanghai Anoky Group
SHE:300067
|
-0.006x |
|
Cullinan Oncology LLC
NASDAQ:CGEM
|
-0.126x |
|
Shanghai Diesel Engine Co Ltd A
SHG:600841
|
-0.045x |
|
Suning Universal Co Ltd
SHE:000718
|
0.008x |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
0.017x |
|
Telsys
TA:TLSY
|
0.107x |
Annual Cash Flow Conversion Efficiency for Shanghai Haixin Group Co Ltd A (1998–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haixin Group Co Ltd A from 1998 to 2025. View Shanghai Haixin Group Co Ltd A stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.92 Billion ≈ $719.45 Million |
CN¥117.69 Million ≈ $17.22 Million |
0.024x | +38.99% |
| 2024-12-31 | CN¥4.50 Billion ≈ $658.63 Million |
CN¥77.52 Million ≈ $11.34 Million |
0.017x | +298.48% |
| 2023-12-31 | CN¥4.14 Billion ≈ $605.13 Million |
CN¥-35.88 Million ≈ $-5.25 Million |
-0.009x | -147.41% |
| 2022-12-31 | CN¥4.02 Billion ≈ $588.08 Million |
CN¥73.56 Million ≈ $10.76 Million |
0.018x | -64.31% |
| 2021-12-31 | CN¥4.28 Billion ≈ $626.71 Million |
CN¥219.65 Million ≈ $32.14 Million |
0.051x | +83.35% |
| 2020-12-31 | CN¥4.38 Billion ≈ $640.86 Million |
CN¥122.50 Million ≈ $17.93 Million |
0.028x | +535.28% |
| 2019-12-31 | CN¥4.05 Billion ≈ $592.42 Million |
CN¥-26.02 Million ≈ $-3.81 Million |
-0.006x | -141.97% |
| 2018-12-31 | CN¥3.63 Billion ≈ $530.49 Million |
CN¥55.50 Million ≈ $8.12 Million |
0.015x | +354.26% |
| 2017-12-31 | CN¥3.95 Billion ≈ $578.00 Million |
CN¥13.31 Million ≈ $1.95 Million |
0.003x | +173.71% |
| 2016-12-31 | CN¥4.34 Billion ≈ $634.93 Million |
CN¥-19.84 Million ≈ $-2.90 Million |
-0.005x | +81.37% |
| 2015-12-31 | CN¥4.80 Billion ≈ $702.85 Million |
CN¥-117.88 Million ≈ $-17.25 Million |
-0.025x | -533.91% |
| 2014-12-31 | CN¥5.54 Billion ≈ $810.69 Million |
CN¥31.34 Million ≈ $4.59 Million |
0.006x | +151.16% |
| 2013-12-31 | CN¥3.22 Billion ≈ $470.54 Million |
CN¥-35.55 Million ≈ $-5.20 Million |
-0.011x | -201.20% |
| 2012-12-31 | CN¥3.11 Billion ≈ $455.40 Million |
CN¥34.00 Million ≈ $4.98 Million |
0.011x | +568.87% |
| 2011-12-31 | CN¥2.76 Billion ≈ $403.21 Million |
CN¥4.50 Million ≈ $658.58K |
0.002x | -91.50% |
| 2010-12-31 | CN¥3.26 Billion ≈ $476.91 Million |
CN¥62.63 Million ≈ $9.16 Million |
0.019x | -59.66% |
| 2009-12-31 | CN¥4.27 Billion ≈ $624.82 Million |
CN¥203.39 Million ≈ $29.76 Million |
0.048x | -17.70% |
| 2008-12-31 | CN¥2.79 Billion ≈ $408.59 Million |
CN¥161.60 Million ≈ $23.65 Million |
0.058x | +333.61% |
| 2007-12-31 | CN¥6.23 Billion ≈ $911.10 Million |
CN¥83.11 Million ≈ $12.16 Million |
0.013x | -21.36% |
| 2006-12-31 | CN¥2.38 Billion ≈ $348.19 Million |
CN¥40.39 Million ≈ $5.91 Million |
0.017x | +286.97% |
| 2005-12-31 | CN¥2.41 Billion ≈ $353.07 Million |
CN¥10.58 Million ≈ $1.55 Million |
0.004x | -95.02% |
| 2004-12-31 | CN¥2.43 Billion ≈ $356.29 Million |
CN¥214.40 Million ≈ $31.37 Million |
0.088x | +21.59% |
| 2003-12-31 | CN¥2.35 Billion ≈ $343.26 Million |
CN¥169.89 Million ≈ $24.86 Million |
0.072x | +81.25% |
| 2002-12-31 | CN¥2.10 Billion ≈ $307.34 Million |
CN¥83.92 Million ≈ $12.28 Million |
0.040x | -71.95% |
| 2001-12-31 | CN¥1.96 Billion ≈ $286.70 Million |
CN¥279.07 Million ≈ $40.84 Million |
0.142x | +1587.30% |
| 2000-12-31 | CN¥1.85 Billion ≈ $270.65 Million |
CN¥-17.71 Million ≈ $-2.59 Million |
-0.010x | -107.68% |
| 1999-12-31 | CN¥970.14 Million ≈ $141.96 Million |
CN¥121.05 Million ≈ $17.71 Million |
0.125x | +12.80% |
| 1998-12-31 | CN¥875.84 Million ≈ $128.16 Million |
CN¥96.89 Million ≈ $14.18 Million |
0.111x | -- |
About Shanghai Haixin Group Co Ltd A
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics… Read more